GenMark Diagnostics (GNMK) Tops Q1 EPS by 4c

GenMark Diagnostics (NASDAQ: GNMK) reported Q1 EPS of ($0.13), $0.04 better than the analyst estimate of ($0.17). Revenue for the quarter came in at $11.1 million versus the consensus estimate of $9.53 million.

For earnings history and earnings-related data on GenMark Diagnostics (GNMK) click here.

---

Serious News for Serious Traders! Try StreetInsider.com Premium Free!

---

You May Also Be Interested In

• Nomura/Instinet Upgrades Genting Singapore (GENS:SP) (GIGNY) to Neutral
• Companhia de Saneamento Básico do Estado de São Paulo - SABESP (SBS) Tops Q2 EPS by 24c
• Blackhawk Network (HAWK) Reports Q2 Loss of $0.07; Offers Guidance